Gennex Laboratories [GENNEX] vs Gujarat Themis [GUJTHEM] Detailed Stock Comparison

Gennex Laboratories Ltd.

BSE
Loading...

Gujarat Themis Biosyn Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Gennex Laboratories Ltd. wins in 7 metrics, Gujarat Themis Biosyn Ltd. wins in 12 metrics, with 0 ties. Gujarat Themis Biosyn Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Gennex Laboratories Ltd. Gujarat Themis Biosyn Ltd. Better
P/E Ratio (TTM) 14.37 73.73 Gennex Laboratories Ltd.
Price-to-Book Ratio 1.19 13.36 Gennex Laboratories Ltd.
Debt-to-Equity Ratio 39.79 27.04 Gujarat Themis Biosyn Ltd.
PEG Ratio -7.90 -17.55 Gennex Laboratories Ltd.
EV/EBITDA 16.60 52.76 Gennex Laboratories Ltd.
Profit Margin (TTM) 12.59% 29.99% Gujarat Themis Biosyn Ltd.
Operating Margin (TTM) 13.54% 40.16% Gujarat Themis Biosyn Ltd.
EBITDA Margin (TTM) 13.54% 40.16% Gujarat Themis Biosyn Ltd.
Return on Equity 9.31% 19.64% Gujarat Themis Biosyn Ltd.
Return on Assets (TTM) 7.08% 16.19% Gujarat Themis Biosyn Ltd.
Free Cash Flow (TTM) $-197.44M $-251.22M Gennex Laboratories Ltd.
Dividend Yield N/A 0.17% N/A
1-Year Return -15.32% 31.69% Gujarat Themis Biosyn Ltd.
Price-to-Sales Ratio (TTM) 1.68 22.23 Gennex Laboratories Ltd.
Enterprise Value $3.08B $36.09B Gujarat Themis Biosyn Ltd.
EV/Revenue Ratio 2.03 22.65 Gennex Laboratories Ltd.
Gross Profit Margin (TTM) 29.90% 83.29% Gujarat Themis Biosyn Ltd.
Revenue per Share (TTM) $6 $15 Gujarat Themis Biosyn Ltd.
Earnings per Share (Diluted) $0.73 $4.40 Gujarat Themis Biosyn Ltd.
Beta (Stock Volatility) 0.60 -0.17 Gujarat Themis Biosyn Ltd.

Gennex Laboratories Ltd. vs Gujarat Themis Biosyn Ltd. Stock Performance Analysis

Loading Price Chart...

GENNEX
GUJTHEM

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Gennex Laboratories Ltd.-1.42%-5.86%9.27%3.17%-21.03%-24.98%
Gujarat Themis Biosyn Ltd.1.72%-7.03%7.92%39.85%0.71%-8.80%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Gennex Laboratories Ltd.-15.32%75.15%88.92%58.41%864.75%897.46%
Gujarat Themis Biosyn Ltd.31.69%84.69%84.69%84.69%84.69%84.69%

Performance & Financial Health Analysis: Gennex Laboratories Ltd. vs Gujarat Themis Biosyn Ltd.

MetricGENNEXGUJTHEM
Market Information
Market Cap i₹2.50B₹35.41B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i401,77279,452
90 Day Avg. Volume i626,792106,446
Last Close₹11.08₹401.80
52 Week Range₹7.05 - ₹17.25₹225.05 - ₹479.00
% from 52W High-35.77%-16.12%
All-Time High₹29.00 (Sep 16, 2024)₹479.00 (Oct 27, 2025)
% from All-Time High-61.79%-16.12%
Growth Metrics
Quarterly Revenue Growth0.07%0.10%
Quarterly Earnings Growth0.13%-0.04%
Financial Health
Profit Margin (TTM) i0.13%0.30%
Operating Margin (TTM) i0.14%0.40%
Return on Equity (TTM) i0.09%0.20%
Debt to Equity (MRQ) i39.7927.04
Cash & Liquidity
Book Value per Share (MRQ)₹8.78₹24.29
Cash per Share (MRQ)₹1.98₹0.92
Operating Cash Flow (TTM) i₹-75,467,000₹970.68M
Levered Free Cash Flow (TTM) i₹181.23M₹487.72M
Dividends
Last 12-Month Dividend Yield iN/A0.17%
Last 12-Month Dividend i₹0.00₹0.67

Valuation & Enterprise Metrics Analysis: Gennex Laboratories Ltd. vs Gujarat Themis Biosyn Ltd.

MetricGENNEX (Apr 24, 2026)GUJTHEM (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i14.3773.73
Forward P/E iN/AN/A
PEG Ratio i-7.90-17.55
Price to Sales (TTM) i1.6822.23
Price to Book (MRQ) i1.1913.36
Market Capitalization
Market Capitalization i₹2.50B₹35.41B
Enterprise Value i₹3.08B₹36.09B
Enterprise Value Metrics
Enterprise to Revenue i2.0322.65
Enterprise to EBITDA i16.6052.76
Risk & Other Metrics
Beta i0.60-0.17
Book Value per Share (MRQ) i₹8.78₹24.29

Financial Statements Comparison: Gennex Laboratories Ltd. vs Gujarat Themis Biosyn Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricGENNEX (2025)GUJTHEM (2025)
Revenue/Sales i1.38B1.51B
Cost of Goods Sold i982.23M318.78M
COGS % of Revenue i71.4%21.1%
Gross Profit i393.29M1.19B
Gross Margin i28.6%78.9%
Research & Development iN/A34.37M
Operating Income (EBIT) i147.25M642.49M
Operating Margin i10.7%42.6%
EBITDA i271.66M713.04M
EBITDA Margin i19.7%47.3%
Pre-Tax Income i215.47M655.38M
Pre-Tax Income % of Revenue i15.7%43.5%
Income Tax i32.75M167.66M
Income Tax % of Revenue i2.4%11.1%
Net Income (Profit) i181.23M487.72M
Profit Margin i13.2%32.3%

Balance Sheet & Liquidity Metrics

MetricGENNEX (2025)GUJTHEM (2025)
Cash & Equivalents i545.89M116.94M
Total Current Assets i1.81B519.73M
Total Current Assets % of Revenue i131.7%34.5%
Total Current Liabilities i445.55M205.60M
Total Current Liabilities % of Revenue i32.4%13.6%
Long-Term Debt i168.93M296.36M
Long-Term Debt % of Revenue i12.3%19.7%
Total Shareholders Equity i1.95B2.48B
Retained Earnings i562.59M2.37B
Retained Earnings % of Revenue i40.9%157.4%
Property, Plant & Equipment i88.69M411.30M

Cash Flow Statement Comparison

MetricGENNEX (2025)GUJTHEM (2025)
Operating Cash Flow i-75.47M970.68M
Operating Cash Flow % of Revenue i-5.5%64.4%
Capital Expenditures i-87.47M-1.16B
Free Cash Flow i-197.44M-251.22M
FCF Margin i-14.4%-16.7%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricGENNEXGUJTHEM
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i242.95M108.97M
Float Shares i156.62M29.52M
% Held by Insiders i33.66%71.98%
% Held by Institutions i0.00%1.18%
% Held by Public i66.34%26.84%

Dividend Analysis & Yield Comparison: Gennex Laboratories Ltd. vs Gujarat Themis Biosyn Ltd.

MetricGENNEXGUJTHEM
Last 12-Month Dividend i₹0.00₹0.67
Last 12-Month Dividend Yield iN/A0.17%
3-Year Avg Annual Dividend i₹0.00₹0.22
3-Year Avg Dividend Yield iN/A0.17%
3-Year Total Dividends i₹0.00₹0.67
Ex-Dividend DateN/ASep 04, 2025